United States · FDA National Drug Code directory
POSACONAZOLE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0254-1016_15fdf050-71cb-476f-a7ce-38c40262f381
- Product NDC
- 0254-1016
- Form
- SUSPENSION
- Composition / generic term
- posaconazole
- Labeler
- ENDO USA, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20230329
- Source listing expiry
- 20271231
Source-listed ingredients
- POSACONAZOLE — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, GLASS in 1 CARTON (0254-1016-36) / 105 mL in 1 BOTTLE, GLASS · 0254-1016-36
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →